Gujarat Terce Laboratories share news and announcements
BSE: 524314Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹36.91.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹27 Cr3,856th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 7 Aug 2026
- 12.7
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.45 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 10.5
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 2.7
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 7 Aug 2026
- 25.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.45 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 31.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 7 Aug 2026
- 25.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 0.13
- Volume, BSEVolume. Shares traded on the last trading day.
- 3,356
Gujarat Terce Laboratories share news and announcements
523 announcements, routine notices left out, newest first. Page 3 of 11.
Mar 2024
Feb 2024
Jan 2024
23 Jan · Board meeting
Meeting on 5 Feb 2024: quarterly results19 Jan · Intimating Shareholder On Graded Surveillance Measure Stage III
Nov 2023
Oct 2023
31 Oct · Board meeting
Meeting on 8 Nov 2023: quarterly results
Aug 2023
Jul 2023
21 Jul · Board meeting
Meeting on 11 Aug 2023: quarterly results
Jun 2023
May 2023
4 May · Board meeting
Meeting on 13 May 2023: audited results
Apr 2023
15 Apr · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
7 Apr · Submission Of Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015 For The Year Ended On March 31, 2023.
6 Apr · Compliance Certificate Pursuant To Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Mar 2023
Jan 2023
31 Jan · Board meeting
25 Jan · Board meeting
Meeting on 31 Jan 2023: quarterly results
Dec 2022
1 Dec · Legal
Exchange has sought clarification from Gujarat Terce Laboratories Ltd on December 1, 2022 with reference to significant movement in price, in order to ensure that investors have latest ....
Nov 2022
25 Nov · Disclosure Under Regulation 23 (9) Of The SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015
25 Nov · Disclosure Under Regulation 23 (9) Of The SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015
14 Nov · Results
14 Nov · Results
14 Nov · Board meeting
3 Nov · Board meeting
Meeting on 14 Nov 2022: quarterly results
Oct 2022
10 Oct · Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2022
Aug 2022
26 Aug · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly <a href="https://www.bseindia.com/stock-share-price/meetings/voting-results/524314 ....6 Aug · Disclosure Pursuant To Regulation 23(9) SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
5 Aug · Board meeting
1 Aug · Reg. 34 (1) Annual Report.